Related references
Note: Only part of the references are listed.The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
Saber Dini et al.
BMC MEDICINE (2020)
Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi
Steve M. Taylor et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
Rob W. van der Pluijm et al.
LANCET (2020)
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2020)
Chloroquine Versus Dihydroartemisinin- Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
Cindy S. Chu et al.
CLINICAL INFECTIOUS DISEASES (2019)
Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention
Daniel Chandramohan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial
Lorenz von Seidlein et al.
PLOS MEDICINE (2019)
Seasonal malaria chemoprevention combined with community case management of malaria in children under 10 years of age, over 5 months, in south-east Senegal: A cluster-randomised trial
Jean Louis A. Ndiaye et al.
PLOS MEDICINE (2019)
Efficacy and Safety of Pyronaridine-Artesunate plus Single-Dose Primaquine for the Treatment of Malaria in Western Cambodia
Rithea Leang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum
Leila S. Ross et al.
CELL HOST & MICROBE (2019)
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
Walter R. J. Taylor et al.
LANCET (2019)
Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial
Rukhsana Ahmed et al.
LANCET INFECTIOUS DISEASES (2019)
Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial
Mary K. Muhindo et al.
LANCET INFECTIOUS DISEASES (2019)
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
Rob W. van der Pluijm et al.
LANCET INFECTIOUS DISEASES (2019)
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
A. Llanos-Cuentas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
M. V. G. Lacerda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Resolving the cause of recurrent Plasmodium vivax malaria probabilistically
Aimee R. Taylor et al.
NATURE COMMUNICATIONS (2019)
Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis
Benedikt Ley et al.
PLOS MEDICINE (2019)
Global access to quality-assured medical products: the Oxford Statement and call to action
Paul N. Newton et al.
LANCET GLOBAL HEALTH (2019)
Drugs in Development for Malaria
Elizabeth A. Ashley et al.
DRUGS (2018)
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial
Issaka Sagara et al.
LANCET (2018)
Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme
Jordi Landier et al.
LANCET (2018)
Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis
Xin Hui S. Chan et al.
LANCET INFECTIOUS DISEASES (2018)
Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa
J. D. Keenan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Malaria elimination in remote communities requires integration of malaria control activities into general health care: an observational study and interrupted time series analysis in Myanmar
Alistair R. D. McLean et al.
BMC MEDICINE (2018)
Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries A Systematic Review and Meta-analysis
Sachiko Ozawa et al.
JAMA NETWORK OPEN (2018)
Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations
Sri Riyati Sugiarto et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2017)
Travel and the emergence of high-level drug resistance in Plasmodium falciparum in southwest Uganda: results from a population-based study
Caroline A. Lynch et al.
MALARIA JOURNAL (2017)
Split dosing of artemisinins does not improve antimalarial therapeutic efficacy
N. J. White et al.
SCIENTIFIC REPORTS (2017)
Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine
Jesmin Permala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Independent Emergence of the Plasmodium falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana
Stella M. Chenet et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Artemisinin Resistance-Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015
Costanza Tacoli et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors
Aung Pyae Phyo et al.
CLINICAL INFECTIOUS DISEASES (2016)
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
Chanaki Amaratunga et al.
LANCET INFECTIOUS DISEASES (2016)
Severe Malaria in African Children - The Need for Continuing Investment
Kathryn Maitland
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
D. Menard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Ric N. Price et al.
LANCET INFECTIOUS DISEASES (2014)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Lethal Malaria: Marchiafava and Bignami Were Right
Nicholas J. White et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Major Burden of Severe Anemia from Non-Falciparum Malaria Species in Southern Papua: A Hospital-Based Surveillance Study
Nicholas M. Douglas et al.
PLOS MEDICINE (2013)
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
Nicholas J. White et al.
MALARIA JOURNAL (2012)
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
Arjen M. Dondorp et al.
LANCET (2010)
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial
Frank Smithuis et al.
LANCET INFECTIOUS DISEASES (2010)
Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria
Nguyen H. Phu et al.
MALARIA JOURNAL (2010)
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial
M. F. Gomes et al.
LANCET (2009)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria
TT Hien et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam
NH Phu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria
K Stepniewska et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Share Paper
